{"id":931,"date":"2019-11-30T13:40:24","date_gmt":"2019-11-30T12:40:24","guid":{"rendered":"https:\/\/dose-innova.ccoo.cat\/?p=931"},"modified":"2019-11-30T13:40:24","modified_gmt":"2019-11-30T12:40:24","slug":"incapacitat-temporal-i-mutues-que-cal-saber-2","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/incapacitat-temporal-i-mutues-que-cal-saber-2\/","title":{"rendered":"Incapacitat temporal i m\u00fatues, que cal saber"},"content":{"rendered":"<p>Quan accedim al lloc de treball, no sols hem de con\u00e8ixer tota la informaci\u00f3 relativa a les tasques que exercirem, sin\u00f3 tamb\u00e9 totes aquelles q\u00fcestions que podrien afectar-nos a curt, mitj\u00e0 i llarg termini. Una d&#8217;elles t\u00e9 a veure amb el referent al proc\u00e9s d&#8217;incapacitat temporal, ja sigui d&#8217;origen com\u00fa o laboral.<\/p>\n<p>A causa dels \u00faltims canvis introdu\u00efts en la normativa, sobretot referent a les m\u00fatues i la Seguretat Social, en la Federaci\u00f3 de Serveis a la Ciutadania de CCOO hem editat aquesta petita guia per a esclarir alguns aspectes clau sobre aquests temes. No obstant aix\u00f2, has de tenir en compte que \u00e9s relativament complex i que aqu\u00ed no podem explicar-t&#8217;ho tot, per la qual cosa t&#8217;aconsellem que davant qualsevol dubte acudeixis al m\u00e9s aviat possible al teu delegat sindical o al propi sindicat per a veure el teu cas particular.    \t    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Quan accedim al lloc de treball, no sols hem de con\u00e8ixer tota la informaci\u00f3 relativa a les tasques que exercirem, sin\u00f3 tamb\u00e9 totes aquelles q\u00fcestions que podrien afectar-nos a curt, &#8230; <a title=\"Incapacitat temporal i m\u00fatues, que cal saber\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/incapacitat-temporal-i-mutues-que-cal-saber-2\/\" aria-label=\"Leer m\u00e1s sobre Incapacitat temporal i m\u00fatues, que cal saber\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":147,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,30],"tags":[],"class_list":["post-931","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-towa-pharmaceutical-europe-app-push","category-prevencion_ca","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=931"}],"version-history":[{"count":0,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/931\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/147"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}